OTAMIXABAN FOR USE IN THE TREATMENT OF NON-ST ELEVATION ACUTE CORONARY SYNDROME IN PATIENTS PLANNED TO UNDERGO CORONARY ARTERY BYPASS GRAFTING
- Application ID: EP13758812
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Sanofi is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.